|
1
|
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis.
|
Brain
|
2011
|
1.50
|
|
2
|
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.
|
J Neuroimmunol
|
2005
|
1.29
|
|
3
|
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline.
|
J Neurosci
|
2009
|
1.22
|
|
4
|
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1.
|
ASN Neuro
|
2011
|
1.19
|
|
5
|
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties.
|
J Neurochem
|
2005
|
1.10
|
|
6
|
Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta.
|
J Neurochem
|
2007
|
0.98
|
|
7
|
Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.
|
PLoS One
|
2010
|
0.91
|
|
8
|
An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding.
|
PLoS One
|
2011
|
0.82
|
|
9
|
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.
|
J Neurochem
|
2012
|
0.77
|
|
10
|
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
|
J Neuroinflammation
|
2012
|
0.76
|